{
    "clinical_study": {
        "@rank": "131246", 
        "acronym": "Propofol TCI", 
        "arm_group": [
            {
                "arm_group_label": "propofol group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "midazolam group", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Many studies address safety of non-anesthesiologist propofol sedation (NAPS) for\n      gastrointestinal endoscopy. Target Controlled Infusion (TCI) is a sophisticated tool for\n      providing optimal sedation regimen and avoiding under or oversedation. The objective of the\n      study is to compare standard moderate sedation during upper endoscopy and colonoscopy versus\n      propofol NAPS."
        }, 
        "brief_title": "Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy", 
        "condition": [
            "Sedation", 
            "Endoscopy"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age < 18 years\n\n          -  American Society of Anesthesiologists risk I-II\n\n          -  patients undergoing to Gastroscopy or Colonoscopy\n\n        Exclusion Criteria:\n\n          -  significant systemic disease\n\n          -  allergic reactions to any of study drugs\n\n          -  chronic use of opioids or psychiatric disorders\n\n          -  pregnancy\n\n          -  Mallampati score > 2\n\n          -  age < 18 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02062177", 
            "org_study_id": "Propofol TCI endoscopy"
        }, 
        "intervention": [
            {
                "arm_group_label": "propofol group", 
                "description": "70 patients are sedated with propofol TCI (Target Controlled Infusion) pump (concentration 1.2-1.6 mcg/ml).", 
                "intervention_name": "Propofol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "midazolam group", 
                "description": "70 patients in group midazolam are sedated with midazolam 0.04 mg/Kg if aged < 70, 0.03 mg/Kg if aged > 70.", 
                "intervention_name": "Midazolam", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Midazolam", 
                "Propofol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 10, 2014", 
        "location": {
            "contact": {
                "email": "lorella.fanti@hsr.it", 
                "last_name": "Lorella Fanti, Dr", 
                "phone": "+39 02.2643.6302"
            }, 
            "facility": {
                "address": {
                    "city": "Milan", 
                    "country": "Italy", 
                    "zip": "20132"
                }, 
                "name": "San Raffaele Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Lorella Fanti, Dr", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Massimo Agostoni, Dr", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy: a Randomized Double Blind Controlled Study", 
        "overall_contact": {
            "email": "testoni.pieralberto@hsr.it", 
            "last_name": "Pier Alberto Testoni, Professor", 
            "phone": "+39 02.2643.2756"
        }, 
        "overall_official": {
            "affiliation": "Vita-Salute San Raffalele University- San Raffaele Hospital", 
            "last_name": "Pier Alberto Testoni, Professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Visual Analog Scale 0-100 will be used to assess the technical difficulty of examination and the satisfaction with sedation of patient experienced by endoscopist", 
                "measure": "Endoscopist's satisfaction (Visual Analog Scale) about sedation", 
                "safety_issue": "Yes", 
                "time_frame": "one day"
            }, 
            {
                "description": "When completely awake, patients will be asked to rate the degree of pain/discomfort and the degree of satisfaction about quality of sedation on a 100 mm visual analog scale (VAS).", 
                "measure": "Patient's satisfaction (Visual Analog Scale) about sedation at the end of procedure", 
                "safety_issue": "Yes", 
                "time_frame": "one day"
            }, 
            {
                "description": "Patients will be contacted by telephone 24-72 hours after discharge and asked about their satisfaction about the quality of sedation, rated on a verbal rating scale, with 0 corresponding to no satisfaction and 100 to complete satisfaction", 
                "measure": "Patient's satisfaction (Visual Analog Scale) about sedation at 24-48 hours after procedure", 
                "safety_issue": "Yes", 
                "time_frame": "one day"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02062177"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universit\u00e0 Vita-Salute San Raffaele", 
            "investigator_full_name": "Testoni Pier Alberto", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "After endoscopy, patients will be transferred to recovery area and evaluated every 5 minutes until they will be ready to be discharged from the Endoscopy Unit. Recovery will be assessed using the Modified Aldrete Scoring System; patients will be considered fit for discharge with a Modified Aldrete Scoring System score of 18 or more, stable vital signs and without nausea, vomiting, or itching.", 
                "measure": "Time (minutes) to dischargeability of patient from endoscopic unit", 
                "safety_issue": "Yes", 
                "time_frame": "one day"
            }, 
            {
                "description": "Number of patients with adverse events (hypotension, bradycardia, hypoxemia,...)", 
                "measure": "Number of Participants with Adverse Events as a Measure of Safety", 
                "safety_issue": "Yes", 
                "time_frame": "one day"
            }
        ], 
        "source": "Universit\u00e0 Vita-Salute San Raffaele", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universit\u00e0 Vita-Salute San Raffaele", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2012"
    }
}